Ref ID: 19499
Author:
Y Fujita1*, S Fujiuchi1, H Suzuki1, T Aritomi1, H Kuroda1, M Takahashi1, A Takeda1, Y Yamazaki1,
T Tsuji1, T Fujikane1
Author address:
1Department of Respiratory Medicine, NHO Asahikawa Medical Center, Asahikawa, Japan
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
Detection of IgG antibody to Aspergillus fumigatus is important for diagnosing chronic pulmonary
aspergillosis. Immunodiffusion assay has been widely used for detecting Aspergillus precipitin,
however, it is seems to be time consuming and lack of sensitivity. Recently, quantitative measurement
of IgG to Aspergillus by using fluorescent immunoenzyme assay (ImmunoCapTM) is commercially
available. In this study, we examined performance of ImmunoCapTM for detecting Aspergillus
precipitin.
Methods:
From January 2007 to August 2013, we determined serum Aspergillus precipitin for 353 consecutive
patients who suspected chronic pulmonary aspergillosis. We also measured specific IgG to Aspergillus
for these collected sera by ImmunoCapTM (Phadia,Uppsala). The patients with history of antifungal
treatment were excluded.
Results:
There were 249 male and 104 female. Median age was 72.6 years. One hundred and twenty-six
patients (35.7%) were positive for Aspergillus precipitin. Aspergillus IgG level was significantly
higher in the precipitin positive group (148.2mgA/L) than in the precipitin negative group
(39.8 mgA/L) (p <0.01). ROC analysis revealed that cut off value of ImmunoCapTM for detecting
Aspergillus precipitin was 50mgA/L. (AUC 0.83, sensitivity0.78, specificity0.76).
Conclusion:
The sensitivity and specificity of ImmunoCapTM for detecting Aspergillus precipitin was acceptable.
Detecting circulating Aspergillus antibody by ImmunoCapTM in the early stage of disease may result
in relatively high false positive rate (0.36). Thus, ImmunoCapTM may alternate with conventional
precipitin test for diagnosing chronic pulmonary aspergillosis. In addition to it, the quantitation of
IgG value might be useful for monitoring marker of antifungal treatment response.
Abstract Number: 27
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a